Treatment reduces breast cancer recurrence by 42% in patients with early-stage breast cancer with an inherited BRCA1 or BRCA2 gene abnormality
Results from the OlympiA clinical trial shows that olaparib reduces breast cancer recurrence by 42%…
Results from the OlympiA clinical trial shows that olaparib reduces breast cancer recurrence by 42%…
More than two-thirds of pancreatic cancer patients harbouring genetic mutations saw their tumour stop growing…
Researchers at the Francis Crick Institute, UK, have found that blocking a specific protein could…
Eva Segelov and Craig Underhill are joined by Philip Parente and Carmel Pezaro for this…
A study by researchers at Queen Mary University in London, UK, has investigated how women…
Two large studies give a much sharper picture of which inherited mutations raise the risk…
The Institute of Cancer Research, London, UK, has strongly welcomed the approval by the European…
Like packaging designed to create a protective environment around a product, the mix of cells…
A key area impacting prostate cancer risk and treatment is germline genetic testing, which involves…
A study by researchers at Mayo Clinic, USA, published this week in the Journal of…